• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Reyon Pharmaceutical Co Ltd

+ Add to Watchlist

102460:KS

20,100 KRW 550 2.81%

As of 01:10:00 ET on 12/26/2014.

Snapshot for Reyon Pharmaceutical Co Ltd (102460)

Open: 19,200 Day's Range: 19,200 - 20,250 Volume: 55,695
Previous Close: 19,550 52wk Range: 16,700 - 32,350 1-Yr Rtn: +10.74%

Stock Chart for 102460

No chart data available.
  • 102460:KS 20,100
  • 1D
  • 1M
  • 1Y
19,550
Interactive 102460 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 102460

Current P/E Ratio (ttm) 22.9714
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.8330
Earnings Per Share (ttm) 875.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 259,290.00
Shares Outstanding (M) 12.90
30 Day Average Volume 42,335
Price/Book (mrq) 1.8469
Price/Sale (ttm) 2.3638
Dividend Indicated Gross Yield 0.75%
Cash Dividend (KRW) 150.0000
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 102460

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 102460

Reyon Pharmaceutical Co., Ltd. produces over the count drug and raw materials for drug. The products include antibiotics, antiphlogistic, and generic drugs.

Jeong Soon-OkVice ChairmanPark Soo-ChunPresident/Rep Director/CEO
Ha Sun-BongVice PresidentJang Chung-WoongVice President
More Company Profile & Key Executives for 102460

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil